|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Laboratoire HP2, Faculte de Medecine-Pharmacie, Grenoble, France
* To whom correspondence should be addressed. E-mail: christophe.ribuot{at}ujf-grenoble.fr.
In this study, we investigated the influence of depth and duration of intermittent hypoxia (IH) on the infarct size development in isolated rat heart. The role of nitric oxide synthase (NOS) and KATP channel was also studied. Wistar male rats were exposed to IH (repetitive cycles of 1 min (40 s with FiO2 5 or 10% followed by 20 s normoxia)), during 30 min or 4 h. Another group was exposed to 4 h of continuous hypoxia with FiO2 10%. 24 h later their hearts were isolated and subjected to a 30-min no-flow global ischemia-120 min reperfusion sequence. For some hearts, L-NAME (a non-selective inhibitor of NOS) or 5-HD (a selective mitochondrial KATP blocker), was infused before ischemia. Infarct size (in % of ventricles) was significantly reduced by prior IH for 4 h (FiO2 10%) (21.8 ± 3.1% vs 33.5 ± 2.5% in sham group). This effect was abolished by L-NAME or 5-HD. Infarct size was not different in groups subjected to either 30 min of IH or to continuous hypoxia compared to sham group. In contrast IH for 4 h (FiO2 5%) significantly increased infarct size (45.1 ± 3.6% vs 33.5 ± 2.5% in sham group). Acute IH for 4 h with a minimal FiO2 of 10% induced a delayed preconditioning against myocardial infarction in the rat, which was abolished by NOS inhibition and mitochondrial KATP channel blockade. Depth, duration and intermittence of hypoxia appeared to be critical for cardioprotection to occur.
This article has been cited by other articles:
![]() |
P. Levy, J-L. Pepin, C. Arnaud, R. Tamisier, J-C. Borel, M. Dematteis, D. Godin-Ribuot, and C. Ribuot Intermittent hypoxia and sleep-disordered breathing: current concepts and perspectives Eur. Respir. J., October 1, 2008; 32(4): 1082 - 1095. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bertuglia Intermittent hypoxia modulates nitric oxide-dependent vasodilation and capillary perfusion during ischemia-reperfusion-induced damage Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1914 - H1922. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Belaidi, P. C. Beguin, P. Levy, C. Ribuot, and D. Godin-Ribuot Prevention of HIF-1 activation and iNOS gene targeting by low-dose cadmium results in loss of myocardial hypoxic preconditioning in the rat Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H901 - H908. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gaitanaki, T. Kalpachidou, I.-K. S. Aggeli, P. Papazafiri, and I. Beis CoCl2 induces protective events via the p38-MAPK signalling pathway and ANP in the perfused amphibian heart J. Exp. Biol., July 1, 2007; 210(13): 2267 - 2277. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Yeung, G. M. Kravtsov, K. M. Ng, T. M. Wong, and M. L. Fung Chronic intermittent hypoxia alters Ca2+ handling in rat cardiomyocytes by augmented Na+/Ca2+ exchange and ryanodine receptor activities in ischemia-reperfusion Am J Physiol Cell Physiol, June 1, 2007; 292(6): C2046 - C2056. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-M. Park and Y. J. Suzuki Effects of intermittent hypoxia on oxidative stress-induced myocardial damage in mice J Appl Physiol, May 1, 2007; 102(5): 1806 - 1814. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. T. McNicholas, M. R. Bonsignore, and the Management Committee of EU COST ACTION B26 Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities Eur. Respir. J., January 1, 2007; 29(1): 156 - 178. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. B. Manukhina, H. F. Downey, and R. T. Mallet Role of nitric oxide in cardiovascular adaptation to intermittent hypoxia. Experimental Biology and Medicine, April 1, 2006; 231(4): 343 - 365. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |